![](/img/cover-not-exists.png)
Randomized double-blind placebo-controlled dose-finding trial of intravenous immunoglobulin (octagam® 10%, octapharma AG) in patients with Alzheimer's disease
Farlow, Martin R., Jessen, Frank, Wietek, Stefan, Melsen, Tina, Haag, Stefan, Dodel, RichardVolume:
6
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2010.05.1783
Date:
July, 2010
File:
PDF, 45 KB
english, 2010